Articles related to WEARABLES

Accelerometer-derived sleep-wake cycle metrics independently predicted incident dementia in 53,448 UK Biobank participants, with predictive improvement comparable to APOE genotype contribution when added to age-only models.

A 2-week randomized trial in 86 adolescents combining personalized sleep scheduling with morning bright-light glasses and evening blue light–blocking glasses shifted circadian timing 45 minutes earlier and added 47 minutes of weeknight sleep versus controls.

“91% (31/34) of study participants stated that they preferred the cuffless Hilo Band over an upper arm blood pressure cuff due to ease of use, convenience, and number of readings.”

This breakthrough in noninvasive, intelligent, and personalized neuromodulation marks the emergence of AI therapeutics in disease treatment.

The Sonu Band, now FDA-cleared for children 12+, showed a -2.74 mean TNSS improvement with no adverse events in a 2-week study.

The P-WCD demonstrated a clinically significant cutaneous adverse device effect rate of only 2.30%, with no severe adverse events reported, suggesting a favorable safety profile for this novel wearable defibrillator.